Pliant Therapeutics Inc. (PLRX) NASDAQ
$15.36 1.22 (8.63%)
Market Cap: $926.60M
As of 05/15/24 04:00 PM EDT. Market closed.
Pliant Therapeutics Inc. (PLRX)
NASDAQ
$15.36
1.22 (8.63%)
Market Cap: $926.60M
As of 05/15/24 04:00 PM EDT. Market closed.
Add to Portfolio
pliant therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. by harnessing the therapeutic potential of integrin biology and tgf-? modulation, pliant aims to prevent or even reverse fibrosis to address the needs of many patients. the company also aims to build a patient registry for certain areas of fibrotic disease to both increase ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Bernard Coulie
Full Time Employees
88,300
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Bernard Coulie
Full Time Employees
88,300
URL
Address
260 Littlefield Avenue, Suite 150, California, South San Francisco, 94080.
PRICE CHART FOR PLIANT THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$14.53
Previous Close
$14.14
Days Range
$14.56 - $16.52
52 week range
$11.21 - $24.74
Volume
1,269,936
Avg. Volume (30 days)
435,087
Market Cap
$926.60M
Dividend Yield
-
P/E
(5.43)
Shares Outstanding
60,325,832
Open
$14.53
Previous Close
$14.14
Days Range
$14.56 - $16.52
52 week range
$11.21 - $24.74
Volume
1,269,936
Avg. Volume (30 days)
435,087
Market Cap
$926.60M
Dividend Yield
-
P/E
(5.43)
Shares Outstanding
60,325,832
FINANCIAL STATEMENTS FOR PLIANT THERAPEUTICS INC
LOADING...
INSIDER TRANSACTIONS FOR PLIANT THERAPEUTICS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Cummings Keith Lamont | Chief Financial Officer | May 02, 2024 | Option Exercise | $2.08 | 21,000 | 43,680 | 271,713 | May 06, 2024, 06:02 AM |
Cummings Keith Lamont | Chief Financial Officer | Jan 17, 2024 | Sale | $17.23 | 9,781 | 168,527 | 194,605 | Jan 19, 2024, 05:19 PM |
Hull Hans | Chief Business Officer | Jan 17, 2024 | Sale | $17.23 | 9,786 | 168,613 | 185,069 | Jan 19, 2024, 05:19 PM |
Coulie Bernard | President and CEO | Jan 17, 2024 | Sale | $17.23 | 25,721 | 443,173 | 316,382 | Jan 19, 2024, 05:19 PM |
Lefebvre Eric | Chief Medical Officer | Jan 17, 2024 | Sale | $17.23 | 10,295 | 177,383 | 156,920 | Jan 19, 2024, 05:18 PM |
Ouimette Mike | General Counsel & Corp. Sec'y | Jan 17, 2024 | Sale | $17.23 | 5,197 | 89,544 | 55,246 | Jan 19, 2024, 05:11 PM |
Hull Hans | Chief Business Officer | Aug 04, 2023 | Option Exercise | $2.08 | 8,791 | 18,285 | 214,905 | Aug 07, 2023, 08:50 PM |
Hull Hans | Chief Business Officer | Aug 03, 2023 | Option Exercise | $2.08 | 1,800 | 3,744 | 207,914 | Aug 07, 2023, 08:50 PM |
Hull Hans | Chief Business Officer | Aug 04, 2023 | Sale | $20.01 | 20,050 | 401,201 | 194,855 | Aug 07, 2023, 08:50 PM |
Hull Hans | Chief Business Officer | Aug 03, 2023 | Sale | $20.00 | 14,869 | 297,380 | 206,114 | Aug 07, 2023, 08:50 PM |
Ouimette Mike | General Counsel & Corp. Sec'y | Jul 20, 2023 | Sale | $17.55 | 4,755 | 83,450 | 60,443 | Jul 21, 2023, 04:40 PM |
Ouimette Mike | General Counsel & Corp. Sec'y | Jul 17, 2023 | Sale | $18.01 | 12,778 | 230,120 | 65,198 | Jul 19, 2023, 08:31 PM |
Lefebvre Eric | Chief Medical Officer | Jul 17, 2023 | Sale | $18.01 | 22,321 | 401,981 | 167,215 | Jul 19, 2023, 08:29 PM |
Hull Hans | Chief Business Officer | Jul 17, 2023 | Sale | $18.01 | 17,937 | 323,029 | 219,183 | Jul 19, 2023, 08:26 PM |
Cummings Keith Lamont | Chief Financial Officer | Jul 17, 2023 | Sale | $18.01 | 19,771 | 356,058 | 203,999 | Jul 19, 2023, 08:23 PM |
Coulie Bernard | President and CEO | Jul 17, 2023 | Sale | $18.01 | 70,150 | 1,263,338 | 342,103 | Jul 19, 2023, 08:20 PM |
Cummings Keith Lamont | Chief Financial Officer | Jun 13, 2023 | Option Exercise | $2.08 | 30,750 | 63,960 | 185,020 | Jun 14, 2023, 06:14 PM |
Cummings Keith Lamont | Chief Financial Officer | Jun 09, 2023 | Option Exercise | $2.08 | 5,800 | 12,064 | 154,270 | Jun 12, 2023, 06:19 PM |
Ouimette Mike | General Counsel & Corp. Sec'y | Apr 03, 2023 | Sale | $26.79 | 2,877 | 77,066 | 50,989 | Apr 03, 2023, 07:07 PM |
Ouimette Mike | General Counsel & Corp. Sec'y | Mar 30, 2023 | Sale | $26.52 | 4,874 | 129,263 | 53,666 | Apr 03, 2023, 07:07 PM |
Lefebvre Eric | Chief Medical Officer | Mar 30, 2023 | Sale | $26.52 | 11,245 | 298,228 | 145,786 | Apr 03, 2023, 07:01 PM |
Hull Hans | Chief Business Officer | Mar 30, 2023 | Sale | $26.52 | 9,036 | 239,643 | 201,964 | Apr 03, 2023, 06:51 PM |
Cummings Keith Lamont | Chief Financial Officer | Mar 30, 2023 | Sale | $26.52 | 9,960 | 264,148 | 148,470 | Apr 03, 2023, 06:48 PM |
Coulie Bernard | President and CEO | Mar 30, 2023 | Sale | $26.52 | 35,339 | 937,222 | 274,753 | Apr 03, 2023, 06:46 PM |
Coulie Bernard | President and CEO | Feb 03, 2023 | Option Exercise | $6.22 | 15,000 | 93,300 | 255,112 | Feb 06, 2023, 05:45 PM |
Coulie Bernard | President and CEO | Feb 02, 2023 | Option Exercise | $6.22 | 15,000 | 93,300 | 255,112 | Feb 06, 2023, 05:45 PM |
Coulie Bernard | President and CEO | Feb 03, 2023 | Sale | $33.61 | 15,000 | 504,200 | 245,374 | Feb 06, 2023, 05:45 PM |
Coulie Bernard | President and CEO | Feb 02, 2023 | Sale | $34.22 | 15,000 | 513,230 | 241,717 | Feb 06, 2023, 05:45 PM |
Coulie Bernard | President and CEO | Jan 31, 2023 | Option Exercise | $3.31 | 15,000 | 49,669 | 255,112 | Feb 01, 2023, 09:43 PM |
Coulie Bernard | President and CEO | Jan 30, 2023 | Option Exercise | $2.08 | 15,000 | 31,200 | 255,112 | Feb 01, 2023, 09:43 PM |
Coulie Bernard | President and CEO | Feb 01, 2023 | Option Exercise | $6.22 | 15,000 | 93,300 | 255,112 | Feb 01, 2023, 09:43 PM |
Coulie Bernard | President and CEO | Jan 31, 2023 | Sale | $34.92 | 15,000 | 523,755 | 240,112 | Feb 01, 2023, 09:43 PM |
Coulie Bernard | President and CEO | Jan 30, 2023 | Sale | $34.14 | 15,000 | 512,116 | 243,717 | Feb 01, 2023, 09:43 PM |
Coulie Bernard | President and CEO | Feb 01, 2023 | Sale | $34.38 | 15,000 | 515,767 | 245,657 | Feb 01, 2023, 09:43 PM |
Coulie Bernard | President and CEO | Jan 26, 2023 | Option Exercise | $2.08 | 15,000 | 31,200 | 255,112 | Jan 27, 2023, 07:15 PM |
Coulie Bernard | President and CEO | Jan 27, 2023 | Option Exercise | $2.08 | 15,000 | 31,200 | 255,112 | Jan 27, 2023, 07:15 PM |
Coulie Bernard | President and CEO | Jan 26, 2023 | Sale | $35.10 | 15,000 | 526,425 | 419,317 | Jan 27, 2023, 07:15 PM |
Coulie Bernard | President and CEO | Jan 26, 2023 | Sale | $35.29 | 15,000 | 529,366 | 240,112 | Jan 27, 2023, 07:15 PM |
Coulie Bernard | President and CEO | Jan 27, 2023 | Sale | $35.13 | 10,000 | 351,255 | 409,538 | Jan 27, 2023, 07:15 PM |
Coulie Bernard | President and CEO | Jan 27, 2023 | Sale | $35.69 | 15,000 | 535,289 | 246,414 | Jan 27, 2023, 07:15 PM |
Coulie Bernard | President and CEO | Jan 24, 2023 | Option Exercise | $2.08 | 15,000 | 31,200 | 108,812 | Jan 25, 2023, 09:00 PM |
Coulie Bernard | President and CEO | Jan 23, 2023 | Option Exercise | $2.08 | 15,000 | 31,200 | 108,812 | Jan 25, 2023, 09:00 PM |
Coulie Bernard | President and CEO | Jan 25, 2023 | Option Exercise | $2.08 | 15,000 | 31,200 | 108,812 | Jan 25, 2023, 09:00 PM |
Coulie Bernard | President and CEO | Jan 23, 2023 | Sale | $35.00 | 15,000 | 525,000 | 434,317 | Jan 25, 2023, 09:00 PM |
Coulie Bernard | President and CEO | Jan 23, 2023 | Sale | $34.10 | 15,000 | 511,567 | 98,662 | Jan 25, 2023, 09:00 PM |
Coulie Bernard | President and CEO | Jan 25, 2023 | Sale | $32.50 | 15,000 | 487,517 | 95,508 | Jan 25, 2023, 09:00 PM |
Coulie Bernard | President and CEO | Jan 24, 2023 | Sale | $30.89 | 15,000 | 463,389 | 93,812 | Jan 25, 2023, 09:00 PM |
Ouimette Mike | General Counsel & Corp. Sec'y | Jan 23, 2023 | Option Exercise | $18.09 | 20,000 | 361,800 | 25,947 | Jan 25, 2023, 09:00 PM |
Ouimette Mike | General Counsel & Corp. Sec'y | Jan 23, 2023 | Sale | $34.19 | 20,000 | 683,878 | 5,947 | Jan 25, 2023, 09:00 PM |
Lefebvre Eric | Chief Medical Officer | Jan 23, 2023 | Sale | $34.48 | 67,500 | 2,327,629 | 76,926 | Jan 25, 2023, 09:00 PM |
Cummings Keith Lamont | Chief Financial Officer | Jan 23, 2023 | Option Exercise | $4.49 | 30,000 | 134,850 | 114,424 | Jan 25, 2023, 09:00 PM |
Cummings Keith Lamont | Chief Financial Officer | Jan 23, 2023 | Sale | $35.00 | 30,000 | 1,050,000 | 84,424 | Jan 25, 2023, 09:00 PM |
Coulie Bernard | President and CEO | Jan 09, 2023 | Option Exercise | $2.08 | 5,000 | 10,400 | 98,812 | Jan 09, 2023, 08:16 PM |
Coulie Bernard | President and CEO | Jan 06, 2023 | Option Exercise | $2.08 | 15,000 | 31,200 | 108,812 | Jan 09, 2023, 08:16 PM |
Coulie Bernard | President and CEO | Jan 09, 2023 | Sale | $19.17 | 5,000 | 95,829 | 93,812 | Jan 09, 2023, 08:16 PM |
Coulie Bernard | President and CEO | Jan 06, 2023 | Sale | $19.04 | 15,000 | 285,584 | 93,812 | Jan 09, 2023, 08:16 PM |
Coulie Bernard | President and CEO | Jan 04, 2023 | Option Exercise | $2.08 | 15,000 | 31,200 | 108,812 | Jan 05, 2023, 07:44 PM |
Coulie Bernard | President and CEO | Jan 03, 2023 | Option Exercise | $2.08 | 15,000 | 31,200 | 108,812 | Jan 05, 2023, 07:44 PM |
Coulie Bernard | President and CEO | Jan 04, 2023 | Sale | $19.06 | 15,000 | 285,941 | 93,812 | Jan 05, 2023, 07:44 PM |
Coulie Bernard | President and CEO | Jan 03, 2023 | Sale | $19.33 | 15,000 | 289,951 | 93,812 | Jan 05, 2023, 07:44 PM |
Cummings Keith Lamont | Chief Financial Officer | Dec 22, 2022 | Option Exercise | $2.08 | 4,000 | 8,320 | 84,424 | Dec 27, 2022, 04:30 PM |
Ouimette Mike | General Counsel & Corp. Sec'y | Dec 22, 2022 | Sale | $19.38 | 2,928 | 56,731 | 5,947 | Dec 23, 2022, 05:34 PM |
Cummings Keith Lamont | Chief Financial Officer | Dec 20, 2022 | Sale | $19.10 | 9,643 | 184,204 | 80,424 | Dec 21, 2022, 09:32 PM |
Coulie Bernard | President and CEO | Dec 20, 2022 | Sale | $19.10 | 34,212 | 653,531 | 93,812 | Dec 21, 2022, 09:32 PM |
Lefebvre Eric | Chief Medical Officer | Dec 20, 2022 | Sale | $19.10 | 10,887 | 207,968 | 144,426 | Dec 21, 2022, 09:32 PM |
Ouimette Mike | General Counsel & Corp. Sec'y | Dec 20, 2022 | Sale | $19.10 | 4,719 | 90,144 | 8,875 | Dec 21, 2022, 09:32 PM |
Hull Hans | Chief Business Officer | Dec 20, 2022 | Sale | $19.10 | 8,748 | 167,108 | 138,191 | Dec 21, 2022, 09:32 PM |
Lefebvre Eric | Chief Medical Officer | Oct 25, 2022 | Sale | $25.05 | 5,000 | 125,241 | 133,437 | Oct 27, 2022, 09:05 PM |
Coulie Bernard | President and CEO | Sep 12, 2022 | Option Exercise | $2.08 | 12,502 | 26,004 | 71,775 | Sep 14, 2022, 05:31 PM |
Coulie Bernard | President and CEO | Sep 12, 2022 | Sale | $22.54 | 12,502 | 281,851 | 59,273 | Sep 14, 2022, 05:31 PM |
Lefebvre Eric | Chief Medical Officer | Jul 11, 2022 | Sale | $20.00 | 3,000 | 60,000 | 138,436 | Jul 13, 2022, 07:06 PM |
Coulie Bernard | President and CEO | Jul 12, 2022 | Option Exercise | $2.08 | 12,498 | 25,996 | 71,771 | Jul 13, 2022, 07:05 PM |
Coulie Bernard | President and CEO | Jul 11, 2022 | Option Exercise | $2.08 | 15,000 | 31,200 | 74,273 | Jul 13, 2022, 07:05 PM |
Coulie Bernard | President and CEO | Jul 12, 2022 | Sale | $22.50 | 12,498 | 281,205 | 59,273 | Jul 13, 2022, 07:05 PM |
Coulie Bernard | President and CEO | Jul 11, 2022 | Sale | $22.50 | 15,000 | 337,500 | 59,273 | Jul 13, 2022, 07:05 PM |
Cummings Keith Lamont | Chief Financial Officer | Sep 03, 2021 | Option Exercise | $2.08 | 20,000 | 41,600 | 67,621 | Sep 03, 2021, 06:27 PM |
Coulie Bernard | President and CEO | Jun 14, 2021 | Sale | $33.03 | 4,000 | 132,102 | 449,560 | Jun 15, 2021, 08:03 PM |
Coulie Bernard | President and CEO | May 14, 2021 | Sale | $28.64 | 3,500 | 100,224 | 453,820 | May 17, 2021, 07:34 PM |
Coulie Bernard | President and CEO | Apr 13, 2021 | Option Exercise | $2.08 | 6,000 | 12,480 | 54,840 | Apr 15, 2021, 08:05 PM |
Coulie Bernard | President and CEO | Apr 14, 2021 | Sale | $30.33 | 3,500 | 106,161 | 456,817 | Apr 15, 2021, 08:05 PM |
Lefebvre Eric | Chief Medical Officer | Mar 18, 2021 | Sale | $39.41 | 12,500 | 492,678 | 150,715 | Mar 19, 2021, 07:09 PM |
Coulie Bernard | President and CEO | Mar 15, 2021 | Sale | $38.52 | 3,500 | 134,835 | 462,495 | Mar 17, 2021, 07:36 PM |
Cummings Keith Lamont | Chief Financial Officer | Mar 05, 2021 | Option Exercise | $2.08 | 20,000 | 41,600 | 47,621 | Mar 05, 2021, 08:51 PM |
Coulie Bernard | President and CEO | Feb 16, 2021 | Sale | $32.67 | 3,500 | 114,352 | 466,117 | Feb 17, 2021, 07:00 PM |
Coulie Bernard | President and CEO | Jan 14, 2021 | Sale | $26.38 | 3,500 | 92,325 | 467,947 | Jan 15, 2021, 07:00 PM |
Hull Hans | Chief Business Officer | Dec 30, 2020 | Option Exercise | $2.08 | 3,500 | 7,280 | 120,746 | Jan 04, 2021, 08:00 PM |
Cummings Keith Lamont | Chief Financial Officer | Dec 21, 2020 | Option Exercise | $2.08 | 4,500 | 9,360 | 27,621 | Dec 23, 2020, 08:00 PM |
Lefebvre Eric | Chief Medical Officer | Dec 18, 2020 | Sale | $26.54 | 12,500 | 331,752 | 167,792 | Dec 21, 2020, 08:00 PM |
Coulie Bernard | President and CEO | Dec 14, 2020 | Sale | $27.37 | 3,500 | 95,790 | 471,154 | Dec 16, 2020, 08:00 PM |
Cummings Keith Lamont | Chief Financial Officer | Dec 01, 2020 | Option Exercise | $3.66 | 18,734 | 68,539 | 41,855 | Dec 02, 2020, 08:00 PM |
Cummings Keith Lamont | Chief Financial Officer | Dec 01, 2020 | Sale | $30.00 | 18,734 | 562,035 | 40,716 | Dec 02, 2020, 08:00 PM |
Cummings Keith Lamont | Chief Financial Officer | Apr 30, 2020 | Option Exercise | $2.08 | 19,300 | 40,144 | 19,300 | Jun 09, 2020, 09:08 PM |
Coulie Bernard | President and CEO | Apr 30, 2020 | Option Exercise | $2.13 | 48,840 | 104,125 | 48,840 | Jun 09, 2020, 09:00 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Cummings Keith Lamont | Chief Financial Officer | 05/02/2024 | 43,680 |
Cummings Keith Lamont | Chief Financial Officer | 01/17/2024 | 168,527 |
Hull Hans | Chief Business Officer | 01/17/2024 | 168,613 |
Coulie Bernard | President and CEO | 01/17/2024 | 443,173 |
Lefebvre Eric | Chief Medical Officer | 01/17/2024 | 177,383 |
Ouimette Mike | General Counsel & Corp. Sec'y | 01/17/2024 | 89,544 |
Hull Hans | Chief Business Officer | 08/04/2023 | 18,285 |
Hull Hans | Chief Business Officer | 08/03/2023 | 3,744 |
Hull Hans | Chief Business Officer | 08/04/2023 | 401,201 |
Hull Hans | Chief Business Officer | 08/03/2023 | 297,380 |
Ouimette Mike | General Counsel & Corp. Sec'y | 07/20/2023 | 83,450 |
Ouimette Mike | General Counsel & Corp. Sec'y | 07/17/2023 | 230,120 |
Lefebvre Eric | Chief Medical Officer | 07/17/2023 | 401,981 |
Hull Hans | Chief Business Officer | 07/17/2023 | 323,029 |
Cummings Keith Lamont | Chief Financial Officer | 07/17/2023 | 356,058 |
Coulie Bernard | President and CEO | 07/17/2023 | 1,263,338 |
Cummings Keith Lamont | Chief Financial Officer | 06/13/2023 | 63,960 |
Cummings Keith Lamont | Chief Financial Officer | 06/09/2023 | 12,064 |
Ouimette Mike | General Counsel & Corp. Sec'y | 04/03/2023 | 77,066 |
Ouimette Mike | General Counsel & Corp. Sec'y | 03/30/2023 | 129,263 |
Lefebvre Eric | Chief Medical Officer | 03/30/2023 | 298,228 |
Hull Hans | Chief Business Officer | 03/30/2023 | 239,643 |
Cummings Keith Lamont | Chief Financial Officer | 03/30/2023 | 264,148 |
Coulie Bernard | President and CEO | 03/30/2023 | 937,222 |
Coulie Bernard | President and CEO | 02/03/2023 | 93,300 |
Coulie Bernard | President and CEO | 02/02/2023 | 93,300 |
Coulie Bernard | President and CEO | 02/03/2023 | 504,200 |
Coulie Bernard | President and CEO | 02/02/2023 | 513,230 |
Coulie Bernard | President and CEO | 01/31/2023 | 49,669 |
Coulie Bernard | President and CEO | 01/30/2023 | 31,200 |
Coulie Bernard | President and CEO | 02/01/2023 | 93,300 |
Coulie Bernard | President and CEO | 01/31/2023 | 523,755 |
Coulie Bernard | President and CEO | 01/30/2023 | 512,116 |
Coulie Bernard | President and CEO | 02/01/2023 | 515,767 |
Coulie Bernard | President and CEO | 01/26/2023 | 31,200 |
Coulie Bernard | President and CEO | 01/27/2023 | 31,200 |
Coulie Bernard | President and CEO | 01/26/2023 | 526,425 |
Coulie Bernard | President and CEO | 01/26/2023 | 529,366 |
Coulie Bernard | President and CEO | 01/27/2023 | 351,255 |
Coulie Bernard | President and CEO | 01/27/2023 | 535,289 |
Coulie Bernard | President and CEO | 01/24/2023 | 31,200 |
Coulie Bernard | President and CEO | 01/23/2023 | 31,200 |
Coulie Bernard | President and CEO | 01/25/2023 | 31,200 |
Coulie Bernard | President and CEO | 01/23/2023 | 525,000 |
Coulie Bernard | President and CEO | 01/23/2023 | 511,567 |
Coulie Bernard | President and CEO | 01/25/2023 | 487,517 |
Coulie Bernard | President and CEO | 01/24/2023 | 463,389 |
Ouimette Mike | General Counsel & Corp. Sec'y | 01/23/2023 | 361,800 |
Ouimette Mike | General Counsel & Corp. Sec'y | 01/23/2023 | 683,878 |
Lefebvre Eric | Chief Medical Officer | 01/23/2023 | 2,327,629 |
Cummings Keith Lamont | Chief Financial Officer | 01/23/2023 | 134,850 |
Cummings Keith Lamont | Chief Financial Officer | 01/23/2023 | 1,050,000 |
Coulie Bernard | President and CEO | 01/09/2023 | 10,400 |
Coulie Bernard | President and CEO | 01/06/2023 | 31,200 |
Coulie Bernard | President and CEO | 01/09/2023 | 95,829 |
Coulie Bernard | President and CEO | 01/06/2023 | 285,584 |
Coulie Bernard | President and CEO | 01/04/2023 | 31,200 |
Coulie Bernard | President and CEO | 01/03/2023 | 31,200 |
Coulie Bernard | President and CEO | 01/04/2023 | 285,941 |
Coulie Bernard | President and CEO | 01/03/2023 | 289,951 |
Cummings Keith Lamont | Chief Financial Officer | 12/22/2022 | 8,320 |
Ouimette Mike | General Counsel & Corp. Sec'y | 12/22/2022 | 56,731 |
Cummings Keith Lamont | Chief Financial Officer | 12/20/2022 | 184,204 |
Coulie Bernard | President and CEO | 12/20/2022 | 653,531 |
Lefebvre Eric | Chief Medical Officer | 12/20/2022 | 207,968 |
Ouimette Mike | General Counsel & Corp. Sec'y | 12/20/2022 | 90,144 |
Hull Hans | Chief Business Officer | 12/20/2022 | 167,108 |
Lefebvre Eric | Chief Medical Officer | 10/25/2022 | 125,241 |
Coulie Bernard | President and CEO | 09/12/2022 | 26,004 |
Coulie Bernard | President and CEO | 09/12/2022 | 281,851 |
Lefebvre Eric | Chief Medical Officer | 07/11/2022 | 60,000 |
Coulie Bernard | President and CEO | 07/12/2022 | 25,996 |
Coulie Bernard | President and CEO | 07/11/2022 | 31,200 |
Coulie Bernard | President and CEO | 07/12/2022 | 281,205 |
Coulie Bernard | President and CEO | 07/11/2022 | 337,500 |
Cummings Keith Lamont | Chief Financial Officer | 09/03/2021 | 41,600 |
Coulie Bernard | President and CEO | 06/14/2021 | 132,102 |
Coulie Bernard | President and CEO | 05/14/2021 | 100,224 |
Coulie Bernard | President and CEO | 04/13/2021 | 12,480 |
Coulie Bernard | President and CEO | 04/14/2021 | 106,161 |
Lefebvre Eric | Chief Medical Officer | 03/18/2021 | 492,678 |
Coulie Bernard | President and CEO | 03/15/2021 | 134,835 |
Cummings Keith Lamont | Chief Financial Officer | 03/05/2021 | 41,600 |
Coulie Bernard | President and CEO | 02/16/2021 | 114,352 |
Coulie Bernard | President and CEO | 01/14/2021 | 92,325 |
Hull Hans | Chief Business Officer | 12/30/2020 | 7,280 |
Cummings Keith Lamont | Chief Financial Officer | 12/21/2020 | 9,360 |
Lefebvre Eric | Chief Medical Officer | 12/18/2020 | 331,752 |
Coulie Bernard | President and CEO | 12/14/2020 | 95,790 |
Cummings Keith Lamont | Chief Financial Officer | 12/01/2020 | 68,539 |
Cummings Keith Lamont | Chief Financial Officer | 12/01/2020 | 562,035 |
Cummings Keith Lamont | Chief Financial Officer | 04/30/2020 | 40,144 |
Coulie Bernard | President and CEO | 04/30/2020 | 104,125 |
Load More Insider Transactions
FUNDS WITH A POSITION IN PLIANT THERAPEUTICS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 4,655,385 | 0.00161% | -3.04% | Other |
RA CAPITAL MANAGEMENT, L.P. | 1,281,000 | 0.24% | No change | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,214,883 | 0.00167% | 2.33% | Other |
CANDRIAM S.C.A. | 548,000 | 0.05% | 20.97% | Other |
RENAISSANCE TECHNOLOGIES LLC | 75,900 | 0.00178% | New | Other |
ALPS ADVISORS INC | 42,485 | 0.00448% | 3.47% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 37,143 | 0.00126% | Exited | Event Driven |
TUDOR INVESTMENT CORP ET AL | 26,897 | 0.00255% | New | Event Driven, Other |
BLACKSTONE INC. | 22,206 | 0.00134% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR PLIANT THERAPEUTICS INC
STOCK BUYBACKS FOR PLIANT THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
0.44%
1Q
09/30/2023
0.83%
2Q
06/30/2023
1.70%
3Q
03/31/2023
7.36%
4Q
12/31/2022
23.18%
5Q
09/30/2022
28.59%
6Q
06/30/2022
66.37%
7Q
03/31/2022
66.63%
8Q
12/31/2021
67.05%
9Q
09/30/2021
67.61%
10Q
06/30/2021
68.35%
11Q
03/31/2021
68.83%
12Q
09/30/2020
69.78%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR PLIANT THERAPEUTICS INC
LOADING...